{
  "id": 17310015,
  "title": "Why Merck Stock Flew Higher on Friday",
  "url": "https://urgent.news/2026/10/30/why-merck-stock-flew-higher-on-friday",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-30T23:58:27.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/10/30/why-merck-stock-flew-higher-on-friday/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "Merck (MRK) experienced a significant rise in its stock price on Friday following the release of its solid third-quarter results on Thursday. The pharmaceutical company's performance surpassed analysts' expectations, with total sales increasing by 5% to over $18 billion. Notably, the non-GAAP (adjusted) net income fell by 4%, yet still reached nearly $6.2 billion. Both metrics exceeded average analyst estimates, and management provided optimistic top- and bottom-line guidance for 2026.\n\nSeveral investment analysts responded positively to Merck's results, raising their price targets. Specifically, Bank of America Securities' Jason Gerberry increased his target from $163 to $165 per share, while JPMorgan Chase's Chris Schott elevated his to $175 from $165. Both analysts retained their 'buy' recommendations for the stock.\n\nDespite the positive outlook, there are concerns about Merck's future. The company's blockbuster cancer drug Keytruda is nearing the end of its patent protection, which could impact its revenue stream. However, Merck boasts a diverse pipeline of potential new treatments, potentially leading to another blockbuster product. Additionally, the company is trading at forward levels similar to other pharmaceutical firms and offers a relatively generous dividend yielding 2.3%. Therefore, the article concludes that Merck presents a solid investment opportunity in the healthcare sector with potential for modest growth and income generation.",
  "summary": "Investors were still buying it in the afterglow of its latest quarterly earnings release.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "Why Merck Stock Flew Higher on Friday",
        "url": "https://urgent.news/2026/10/31/why-merck-stock-flew-higher-on-friday",
        "published": "2026-10-31T00:18:27.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}